{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.17643"}, {"@name": "filename", "#text": "24449_2775-9570-1-PB.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "230\n\nInflu\u00eancia do sistema de liberta\u00e7\u00e3o na permea\u00e7\u00e3o de uma mol\u00e9cula hidrof\u00edlica\n\n1 2 1 1 2\nCatarina Pinto Reis , Patricia Carvalho , Maguie Cangueiro , C\u00e1tia Fernandes  , Catarina Rosado\n\n1\n Laboratory of Nanoscience and Biomedical Nanotechnology, Universidade Lus\u00f3fona de Humanidades e \n\nTecnologias, Campo Grande 376, 1749-024 Lisboa \u2013 Portugal\n2\n Experimental Dermatology Unit, Universidade Lus\u00f3fona de Humanidades e Tecnologias, Campo Grande 376, \n\n1749-024 Lisboa \u2013 Portugal\nE-mail: catarina.rosado@ulusofona.pt\n\n__________________________________________________________________________________\nResumo\nDiferentes estrat\u00e9gias t\u00eam sido usadas para aumentar a efic\u00e1cia e a seguran\u00e7a n\u00e3o s\u00f3 de medicamentos t\u00f3picos e transd\u00e9rmicos, \nmas tamb\u00e9m de produtos cosm\u00e9ticos. Avan\u00e7os na tecnologia de encapsula\u00e7\u00e3o levaram ao desenvolvimento de pol\u00edmeros \nbiodegrad\u00e1veis multifuncionais invocando capacidades promotoras de permea\u00e7\u00e3o, permitindo uma liberta\u00e7\u00e3o controlada de \nf\u00e1rmacos ou com propriedades protectoras. O objectivo deste estudo foi aplicar um pol\u00edmero de origem natural \u2013 o alginato- na \nencapsula\u00e7\u00e3o de uma mol\u00e9cula hidrofilica modelo- a cafe\u00edna.\nEste permeante modelo foi encapsulado em tr\u00eas sistemas diferentes de alginato - macrosferas secas, hidratadas e microparticulas \nde c\u00e1lcio-alginato. Adicionalmente, a cafe\u00edna tamb\u00e9m foi incorporada em tr\u00eas formula\u00e7\u00f5es passivas - uma solu\u00e7\u00e3o aquosa, um \ngel de Carbopol\u00a9 e um creme O/A. Foram feitos estudos de difus\u00e3o in vitro com c\u00e9lulas de Franz, utilizando membranas de \npolidimetilsiloxano como modelo da epiderme humana. Quantidades equivalentes das diferentes formula\u00e7\u00f5es de cafe\u00edna foram \ncolocadas no compartimento dador das c\u00e9lulas de Franz. Foram recolhidas amostras do compartimento receptor a cada 2 horas, \ndurante 8 horas. Os v\u00e1rios fluxos em estado estacion\u00e1rio foram calculados.\nOs fluxos mais elevados foram obtidos a partir do creme O/A e as macrosferas secas de alginato. A liberta\u00e7\u00e3o mais lenta de \ncafe\u00edna foi observada quando esta foi encapsulada em macrosferas hidratadas e nas microsferas. Estes diferentes perfis de \npermea\u00e7\u00e3o podem ser explicados pela natureza porosa destes \u00faltimos e por um mecanismo de troca i\u00f3nica.\nEstes resultados s\u00e3o indicativos de que esta tecnologia pode ser usada com sucesso na modula\u00e7\u00e3o da biodisponibilidade de \nmol\u00e9culas para administra\u00e7\u00e3o transcut\u00e2nea. Os pol\u00edmeros de alginato parecem particularmente adequados \u00e0 utiliza\u00e7\u00e3o na \nliberta\u00e7\u00e3o controlada de f\u00e1rmacos com elevada pot\u00eancia farmacol\u00f3gica e estreitas janelas terap\u00eauticas. Por outro lado, a sua \naplicabilidade tamb\u00e9m poder\u00e1 ser estendida a ingredientes cosm\u00e9ticos que, por raz\u00f5es de seguran\u00e7a, devem estar limitados \u00e0s \ncamadas mais superficiais da pele.\n\nPalavras chave: Terapia transd\u00e9rmica, estudos de permea\u00e7\u00e3o in vitro, alginato, macrosferas, micropart\u00edculas\n___________________________________________________________________________________________________\nAbstract\n\n________________________________________________________________________________________________\n\nRev. Lus\u00f3fona de Ci\u00eancias e Tecnologias da Sa\u00fade, \nVers\u00e3o electr\u00f3nica: http://revistas.ulusofona.pt/index.php/revistasaude\n\nThe influence of the delivery systems over the permeation of an hydrophilic active\n\nOver the years different strategies have been employed to increase the efficacy and safety of not only topical and transdermal \nmedicines, but also of cosmetics. The encapsulation technology has enabled the development of multifunctional biodegradable \npolymers claiming permeation enhancement features, controlled release or protective properties. The objective of this study was \nto test the performance of a natural polymer- alginate- in the encapsulation of a model hydrophilic permeant- caffeine.\nThe model permeant was encapsulated into three different alginate systems - dry beads, hydrated beads and calcium-alginate \nmicroparticles. Additionally, free caffeine was included in three passive formulations - an aqueous solution, a Carbopol\u00a9 gel \nand an O/W cream. In vitro diffusion studies with Franz cells were conducted using silastic membranes as a model for human \nepidermis. Equal amounts of the different caffeine formulations were placed in the donor compartment of the diffusion cells. \nSamples of the receptor phase were collected every 2 hours for 8 hours. The multiple steady-state fluxes of caffeine were \ndetermined.\nHigh flux values were achieved with the O/W cream and dry alginate beads. Conversely, the release rate of caffeine was the \nlowest when caffeine was encapsulated in hydrated beads and alginate microspheres. The different permeation profiles obtained \nwith hydrated and dry beads are probably attributable to the porous nature of the latter and also to an ion exchange mechanism.\nThese results indicate that this encapsulation technology can be successfully used to modulate the bioavailability of molecules \nfor transdermal administration. Alginate polymers seem suitable to be employed in the controlled release of drugs with a high \npharmacological potency and small therapeutic windows. On the other hand, its applicability can be extended to cosmetic \ningredients that, for safety reasons, should be limited to the superficial layers of the skin.\n\nKeywords: Transdermal delivery, in vitro permeation studies, alginate, beads, microparticles\n\nAceite em 04/10/2010\n2010; (7) 2: 230 239-\n\nCi\u00eancias Biofarmac\u00eauticas / Biopharmaceuticals Sciences\n\n\n\n 231\n\n Catarina Pinto Reis et al.\n\nIntrodu\u00e7\u00e3o\n\nNos sistemas transd\u00e9rmicos pretende-se uma \npenetra\u00e7\u00e3o transcut\u00e2nea da mol\u00e9cula activa pelo que os \nformuladores procuram optimizar a sua absor\u00e7\u00e3o. Por \noutro lado, h\u00e1 alguma preocupa\u00e7\u00e3o das entidades \nreguladoras com a exposi\u00e7\u00e3o cut\u00e2nea ao potencial \nt\u00f3xico de subst\u00e2ncias inclu\u00eddas nos medicamentos ou de \ningredientes cosm\u00e9ticos. Ao longo dos anos t\u00eam sido \ndesenvolvidas m\u00faltiplas estrat\u00e9gias para obter uma \nliberta\u00e7\u00e3o controlada dos componentes de formula\u00e7\u00f5es \ntransd\u00e9rmicas, como a utiliza\u00e7\u00e3o de matrizes de \n\n[1-3]\ndiferentes materiais , de promotores ou retardantes de \n\n[5]\npermea\u00e7\u00e3o , pol\u00edmeros marcados molecularmente   ou \n\n[6]\nde microemuls\u00f5es  .\nAvan\u00e7os na tecnologia de encapsula\u00e7\u00e3o levaram ao \ndesenvolvimento de pol\u00edmeros biodegrad\u00e1veis \nmultifuncionais invocando capacidades promotoras de \npermea\u00e7\u00e3o, permitindo uma liberta\u00e7\u00e3o controlada de \nf\u00e1rmacos, ou com propriedades protectoras. Nos \n\u00faltimos anos tem-se notado um interesse crescente em \nbiopol\u00edmeros por parte da ind\u00fastria farmac\u00eautica. Os \npol\u00edmeros obtidos de fontes naturais renov\u00e1veis \nadquiriram particular destaque devido ao seu baixo \ncusto, grande disponibilidade, solubilidade em \u00e1gua, \nbiocompatibilidade, biodegradabilidade e capacidade \nformadora de geles. A utiliza\u00e7\u00e3o de alginato remonta \n\n[7,8]\naos anos 40 do s\u00e9culo XX  . Este polissac\u00e1rido, obtido \na partir de algas castanhas ou bact\u00e9rias presentes no \nsolo, \u00e9 biodegrad\u00e1vel e biocompat\u00edvel e forma \nrapidamente complexos i\u00f3nicos com cati\u00f5es divalentes \ncomo o c\u00e1lcio. Os sistemas de alginato podem ser \npreparados atrav\u00e9s de m\u00e9todos de gelifica\u00e7\u00e3o interna ou \nexterna, que produzem sistemas com diferentes perfis \n\n[9,10]\nde liberta\u00e7\u00e3o  . De forma resumida, o m\u00e9todo de \ngelifica\u00e7\u00e3o externa envolve a difus\u00e3o de c\u00e1lcio para o \ninterior da gota aquosa de alginato, ou seja, o gel move-\nse desde a superf\u00edcie da gota at\u00e9 ao seu interior. A \nforma\u00e7\u00e3o de part\u00edculas atrav\u00e9s do m\u00e9todo de \ngelifica\u00e7\u00e3o interna envolve a liberta\u00e7\u00e3o de c\u00e1lcio desde \num complexo insol\u00favel contido dentro da matriz de \n\n[11,12]\nalginato atrav\u00e9s de uma redu\u00e7\u00e3o de pH  . Como \nexemplo de utiliza\u00e7\u00f5es correntes de alginato podem \n\n[13-15] [16]\ndestacar-se a encapsula\u00e7\u00e3o de c\u00e9lulas  , bact\u00e9rias  , \n\n[17] [18-20]\nleveduras  , f\u00e1rmacos  e outros compostos n\u00e3o \n\n[21-22]\nbiol\u00f3gicos  .\nO objectivo deste estudo foi investigar os efeitos da \nencapsula\u00e7\u00e3o em sistemas de part\u00edculas de alginato de \ndiferentes di\u00e2metros e comparar a permea\u00e7\u00e3o \ntranscut\u00e2nea do f\u00e1rmaco modelo obtida com estes \nsistemas com aquela obtida atrav\u00e9s de formula\u00e7\u00f5es \nconvencionais de f\u00e1rmaco livre.\n\nIntroduction\n\nIn transdermal drug delivery, skin penetration of the \nactive molecule is a prerequisite and pharmaceutical \nscientists seek to optimise absorption. Conversely, \nthere is often concern about dermal exposure to the \npotential toxicity of substances included in drug \nformulations or in cosmetic ingredients. Over the years \nmultiple strategies have been employed to attempt \ncontrolled release of transdermal formulations, such as \n\n[1-3]\nthe use of different matrix systems materials  , \n\n[4]\npenetration enhancers and retardants  , molecularly \n\n[5] [6]\nimprinted polymers  or microemulsions  . \nThe encapsulation technology has enabled the \ndevelopment of multifunctional polymers claiming \ncontrolled release, permeation enhancement features \nor protective properties. Over the last few years, \npharmaceutical industries have shown an increased \ninterest in biopolymers. Polymers prepared from \nrenewable natural resources have become increasingly \nimportant because of their low cost, ready availability, \nwater-solubility, biocompatibility, biodegradability \nand gel forming ability. The use of alginate as a \n\n[7,8]\nbiomaterial can be traced to the 1940's  . This \nhydrophilic polysaccharide, obtained from brown \nalgae or soil bacteria, is biodegradable and \nbiocompatible and rapidly forms ionic complexes with \ndivalent cations such as calcium. Alginate systems can \nbe mainly prepared by internal or external gelation \nmethods or by other methods, which produce \nstructurally different carriers with subsequent distinct \n\n[9,10]\nrelease properties  . Briefly, the external gelation \nmethod involves the diffusion of calcium into the \naqueous alginate droplet, thus the gel front moves from \nthe bead surface inward toward the core. The formation \nof particles using the internal gelation method involved \nthe liberation of calcium from an insoluble complex \ncontained within the alginate matrix through a pH \n\n[11,12]\nreduction  . Current applications of alginate include \n\n [16] [17]\nencapsulation of cells , bacteria  , yeast cells  , \n\n[18-20] [21-22]\ndrugs   and other non-biological compounds .\nThe aims of this study were to investigate the effects of \nthe encapsulation in alginate particles of different \ndiameters and to determine the skin permeation of the \nmodel drug from the alginate particle systems and to \ncompare it with those obtained from conventional free \ndrug formulations. \n\n[13-15]\n\n\n\n232\n\nInflu\u00eancia do sistema de liberta\u00e7\u00e3o na permea\u00e7\u00e3o de uma mol\u00e9cula hidrof\u00edlica\nThe influence of different delivery systems in the permeation of an hydrophilic active\n\nMateriais e M\u00e9todos\n\nCafe\u00edna, hidr\u00f3xido de s\u00f3dio, propilparabeno, cloreto de \nc\u00e1lcio, sal de alginato de s\u00f3dio, Span 80 e \nhidrogenofosfato diss\u00f3dico dihidratado foram obtidos a \npartir da Sigma-Aldrich (Steinheim, Alemanha). \nCarbopol 940, lauril sulfato de s\u00f3dio, propilenoglicol e \nvaselina foram obtidos a partir de Jos\u00e9 M. Vaz Pereira \n(Lisboa, Portugal). Cloreto de s\u00f3dio e \u00e1cido ac\u00e9tico \nforam fornecidos por Panreac Quimica SA. (Barcelona, \nEspanha). Metilparabeno foi obtido a partir da \nApplichem (Darmstadt, Alemanha). Carbonato de \nc\u00e1lcio foi fornecido pela Merck (Darmstadt, Alemanha) \ne a parafina l\u00edquida de Fagron Iberica (Barcelona, \nEspanha). Dihidrogenofosfato de s\u00f3dio dihidratado foi \nobtido a partir da Riedel-de-Haen (Steinheim, \nAlemanha).\nAs membranas de polidimetilsiloxano com uma \nespessura de 75 \u00b5m foram fornecidas por Dow Corning \nEurope S.A. (Seneffe, B\u00e9lgica).\n\nFormula\u00e7\u00f5es\n\nGel\nA cafe\u00edna foi dissolvida em 90% do volume de \u00e1gua e, \nem seguida, o Carbopol 940 foi adicionado lentamente \nsob agita\u00e7\u00e3o continua. A mistura foi colocada no banho \nde ultra-sons durante 20 minutos. O hidr\u00f3xido de s\u00f3dio \nfoi dissolvido na quantidade de \u00e1gua restante e em \nseguida adicionado \u00e0 solu\u00e7\u00e3o de cafe\u00edna sob agita\u00e7\u00e3o \nsuave. A mistura resultante foi misturada por agita\u00e7\u00e3o \nlenta at\u00e9 \u00e0 forma\u00e7\u00e3o do gel, que foi posteriormente \nembalado e etiquetado.\n\nCreme O/A\nO \u00e1lcool estear\u00edlico e a vaselina foram fundidos num \nbanho a 75\u00b0C. Os outros ingredientes foram dissolvidos \nem \u00e1gua destilada e aquecidos \u00e0 mesma temperatura. A \nfase oleosa foi transferida para um almofariz \npreviamente aquecido e, em seguida, foi-lhe adicionada \na fase aquosa. Esta mistura foi continuamente agitada \nat\u00e9 \u00e0 forma\u00e7\u00e3o de um creme homog\u00e9neo.\n\nMacrosferas secas e hidratadas- M\u00e9todo de gelifica\u00e7\u00e3o \nexterna\nUma solu\u00e7\u00e3o contendo 2% (m/v) de alginato de s\u00f3dio \nfoi gotejada atrav\u00e9s de uma ponta de seringa para uma \nsolu\u00e7\u00e3o aquosa de cloreto de c\u00e1lcio 50 mM.\nAs macrosferas hidratadas foram separadas da fase \naquosa por filtra\u00e7\u00e3o. Uma parte do lote foi colocada no \nfrigor\u00edfico durante 3 semanas, de forma a obter \nmacrosferas secas.\n\nMicropart\u00edculas \u2013 M\u00e9todo de gelifica\u00e7\u00e3o interna\nO primeiro passo consistiu na prepara\u00e7\u00e3o de uma \nsolu\u00e7\u00e3o de alginato a 2%, 1% de cafe\u00edna e 3,5 mL de \n\nMaterials and Methods\n\nCaffeine, sodium hydroxide, propylparaben, calcium \nchloride, sodium alginate salt, Span 80 and disodium \nhydrogen phosphate dihydrate were purchased from \nSigma-Aldrich (Steinheim, Germany). Carbopol 940, \nsodium lauryl sulphate, propylene glycol and \npetrolatum were obtained from Jos\u00e9 M. Vaz Pereira \n(Lisbon, Portugal). Sodium chloride and acetic acid \nwere purchased from Panreac Quimica SA. \n(Barcelona, Spain). Methylparaben was obtained from \nApplichem (Darmstadt, Germany). Calcium carbonate \nwas purchased from Merck (Darmstadt, Germany) and \nmineral oil from Fagron Iberica (Barcelona, Spain). \nSodium dihydrogen phosphate dehydrate was \npurchased from Riedel-de-Haen (Steinheim, \nGermany).\nPolydimethylsiloxane membranes with a thickness of \n75 \u00b5m were supplied by Dow Corning Europe S.A. \n(Seneffe, Belgium).\n\nFormulations\n\nGel\nCaffeine was dissolved in 90% of the volume of water \nand then Carbopol 940 was slowly added under \ncontinuous stirring. The mixture was placed in the \nultrasonic bath for 20 minutes. Sodium hydroxide was \ndissolved in the remaining amount of water and then \nadded to the caffeine solution by gentle agitation. The \nresulting mixture was mixed by slow agitation until the \ngel was formed. The gel was packed and labeled.\n\nO/W Cream \nStearyl alcohol and petrolatum were melted using a \nbath at 75\u00baC. The other ingredients were dissolved in \ndistilled water and heated at 75\u00ba C. The oil phase was \ntransferred to a mortar previously warmed and then the \nwater phase was slowly added to the first one. The \nmixture was continuously stirred until a homogenous \ncream was formed.\n\nDry beads and hydrated beads \u2013 External gelation \ntechnology\nA solution containing 2% (w/v) sodium alginate was \nextruded through a syringe tip needle into a 50 mM \ncalcium chloride solution. \nHydrated beads were separated from the aqueous phase \nby filtration. Part of this batch was kept in the fridge for \nthree weeks, in order to obtain dry beads.\n\nMicroparticles \u2013 Internal gelation technology\nThe first step consisted in the preparation of a 2% \nalginate solution, 1% of caffeine and 3.5 mL of calcium \n\n\n\n 233\n\ncarbonato de c\u00e1lcio (suspens\u00e3o a 5%, m/v). A mistura \nfoi deixada sob agita\u00e7\u00e3o num agitador orbital durante \nalguns minutos.\nFoi preparada uma fase oleosa com 50 mL de parafina \nl\u00edquida e Span 80 e colocada sob agita\u00e7\u00e3o. Em seguida, \nfoi adicionada lentamente a fase aquosa acima descrita. \nSubsequentemente, a gelifica\u00e7\u00e3o do alginato foi \nconseguida por adi\u00e7\u00e3o de 20 mL de parafina liquida e \n\u00e1cido ac\u00e9tico. As micropart\u00edculas resultantes foram \nrecuperadas atrav\u00e9s de sucessivos ciclos de \ncentrifuga\u00e7\u00e3o e solventes desidratantes.\n\nEstudos de difus\u00e3o\n\nA permea\u00e7\u00e3o de cafe\u00edna de diferentes formula\u00e7\u00f5es foi \ninvestigada usando c\u00e9lulas de Franz est\u00e1ticas com um \nvolume receptor de 4 mL e uma \u00e1rea de difus\u00e3o de 0,95 \ncm2.\nA fase receptora consistiu num tamp\u00e3o fosfato PBS a \npH=7,4. Foram cortadas por\u00e7\u00f5es apropriadas de \npolidimetilsiloxano, que foram lavadas com \u00e1gua de \nforma a eliminar algum contaminante superficial. \nAl\u00edquotas id\u00eanticas de cada formula\u00e7\u00e3o, contendo 1 ou \n1,5% (m/m) de cafe\u00edna foram colocadas no \ncompartimento dador.\nO compartimento receptor de cada c\u00e9lula foi \nsubmergido num banho de \u00e1gua a 37\u00b0C (fig.1). O \ncompartimento dador ficou sob oclus\u00e3o durante toda a \nexperi\u00eancia. Em intervalos pr\u00e9-definidos, 500 \u00b5L de \nfase receptora foram recolhidos para an\u00e1lise e \nsubstitu\u00eddos por um volume equivalente de l\u00edquido \nreceptor fresco.\n\ncarbonate (suspension at 5%, w/v). The mixture was \nleft under agitation on an orbital shaker for a few \nminutes.\nAn oily phase was also prepared with 50 mL of mineral \noil and Span 80 under stirring. Then, the previous \naqueous phase was slowly added to the oily phase \nunder stirring. Subsequently, gelation of alginate was \ndone by addition of 20 mL of liquid paraffin with acetic \nacid. Resultant microparticles where then recovered by \nusing centrifugation cycles and dehydrating solvents.\n \n\nDiffusion studies\n\nPermeation of caffeine from the different formulations \nwas investigated using Franz-type static glass diffusion \ncells with a receptor volume of 4 mL and a diffusion \narea of 0.95 cm2. \nThe receptor phase was PBS at pH=7.4. Synthetic \nmembranes of polydimethylsiloxane were cut to size \nand then washed with water in order to remove surface \ncontamination. Calculated amounts of the different \nformulations, containing 1 or 1.5% (w/w) caffeine, \nwere placed in the donor compartment of the diffusion \ncells.\nThe receptor compartment was immersed in a water \nbath at 37\u00baC (fig.1). The donor compartment remained \noccluded throughout the experiment. At defined time \npoints, 500 \u00ecL of receptor medium was collected for \nanalysis and replaced with an equivalent volume of \nfresh receptor fluid.\n\nFigura  1 \u2013 Formato experimental com c\u00e9lulas de difus\u00e3o de Franz.\nExperimental set-up with Franz-diffusion cell. Figure 1 - \n\n Catarina Pinto Reis et al.\n\n\n\n234\n\nAn\u00e1lise dos dados\n\nA quantifica\u00e7\u00e3o das amostras foi realizada num \nespectrofot\u00f3metro UV a 273 nm. Os fluxos de cafe\u00edna \nem cada sistema foram determinados atrav\u00e9s do declive \ndo gr\u00e1fico do cumulativo da quantidade de f\u00e1rmaco \ndifundida versus tempo, depois de ter sido alcan\u00e7ado o \nestado estacion\u00e1rio. O coeficiente de permeabilidade \nfoi determinado atrav\u00e9s da raz\u00e3o entre fluxos e da \nconcentra\u00e7\u00e3o do agente permeante em cada ve\u00edculo.\nA an\u00e1lise estat\u00edstica foi feita atrav\u00e9s de testes n\u00e3o-\nparam\u00e9tricos (Kruskal-Wallis e Mann-Whitney). As \ndiferen\u00e7as foram consideradas significativas quando p \n<0,05.\n\nResultados e Discuss\u00e3o\n\nComo descrito anteriormente, o objectivo deste estudo \nincidiu na avalia\u00e7\u00e3o do comportamento do alginato \nquando aplicado na encapsula\u00e7\u00e3o da cafe\u00edna. \nDependendo do sistema testado foram obtidos fluxos \ndiferentes conforme representa a figura 2 e Tabela 1. \nNeste estudo, os resultados dos fluxos demonstraram a \nseguinte tend\u00eancia: micropart\u00edculas &lt;macroesferas \nhidratadas &lt;gel &lt;creme&lt;solu\u00e7\u00e3o aquosa &lt;\nmacroesferas secas. A maior taxa de liberta\u00e7\u00e3o de \ncafe\u00edna foi observada com as macroesferas secas e a \nmenor foi obtida com as micropart\u00edculas. Os perfis de \npermea\u00e7\u00e3o da cafe\u00edna a partir dos diferentes sistemas \npodem ser analisados nas figuras 3 e 4.\n\nData analysis\n\nSample analysis was performed on a UV detector set at \n273 nm. Steady-state fluxes of caffeine in each system \nwere determined through the slope of the graph \ncumulative amount diffused versus time obtained once \nsteady-state diffusion was reached. The permeability \ncoefficient was determined through the ratio of the \nflux-values and the concentration of the permeant in \neach vehicle.\nStatistical analysis was conducted using non-\nparametric tests (Kruskal-Wallis and Mann-Whitney). \nThe differences were considered significant when \np<0.05.\n\nResults and Discussion\n\nAs stated before, the objective of this study was to test \nthe performance of alginate in the encapsulation of \ncaffeine. Depending of the tested system, different \nfluxes were obtained, as seen in Fig 2 and Table 1. In \nthis study, flux results showed the following tendency: \nmicroparticles<hydrated beads<gel<cream<aqueous \nsolution<dry beads. The highest release rate of caffeine \nwas observed with dry beads and the lowest flux was \nachieved from microparticles. The permeation profiles \nof caffeine in the different systems can be seen in \nfigures 3 and 4.\n\nFigura  2 \u2013 Valores de fluxo das formula\u00e7\u00f5es testadas (m\u00e9dia \u00b1DP, n=4 para todos os\n sistemas excepto n=5 no caso das micropart\u00edculas). \n\nFlux values of the tested formulations (mean \u00b1 SD, n=4 for \nall systems except n=5 for microparticles).\n\n Figure 2 - \n\nInflu\u00eancia do sistema de liberta\u00e7\u00e3o na permea\u00e7\u00e3o de uma mol\u00e9cula hidrof\u00edlica\nThe influence of different delivery systems in the permeation of an hydrophilic active\n\n\n\n 235\n\nDeve salientar-se que a compara\u00e7\u00e3o de todos os \nve\u00edculos \u00e9 poss\u00edvel, uma vez as vari\u00e1veis experimentais, \ndesignadamente, a \u00e1rea de difus\u00e3o, o volume da c\u00e9lula, \na espessura e o tipo de membrana foram constantes para \ntodas as formula\u00e7\u00f5es testadas. Pode-se, ainda, observar \nque a concentra\u00e7\u00e3o de cafe\u00edna n\u00e3o \u00e9 exactamente a \nmesma para todos os ve\u00edculos. Foram utilizadas \nconcentra\u00e7\u00f5es de cafe\u00edna de 1 ou 1,5%. O efeito da dose \n\u00e9 controverso. Alguns trabalhos demonstraram que uma \n\nIt should be noted that the comparison of all vehicles is \npossible since experimental variables such as diffusion \narea, cell volume, thickness and type of membrane \nwere the same for all tested formulations. It could be \npointed out that the concentration of caffeine is not \nexactly the same in all the vehicles, since either 1 or \n1.5% concentrations were used. However, the dose \neffect is controversial and some studies showed that an \nhigh concentration of permeant does not necessarily \n\nFigura  3 \u2013 Perfis de permea\u00e7\u00e3o das formula\u00e7\u00f5es \ntestadas (m\u00e9dia \u00b1 DP, n= 4)\n\n Figure 3 - Permeation profiles in the tested \nformulations (mean \u00b1 SD, n= 4).\n\nFigura  4 \u2013 Perfis de permea\u00e7\u00e3o da cafe\u00edna em \nmicropart\u00edculas (m\u00e9dia \u00b1 DP, n =5). \n\n Figure 4 - Permeation profiles of caffeine from \nthe microparticles (mean \u00b1 SD, n =5).\n\nFormula\u00e7\u00f5es (Conc. de cafeina %, m/m) \n\nDelivery systems (Conc. of caffeine % , w/w) \n\nFluxo / Flux \n\n(\u00b5g/cm\n2\n.h\n\n-1\n) \n\nK px10\n3 \n(cm.h\n\n-1\n) \n\nSolu\u00e7\u00e3o aquosa /Aqueous solution (1.5%) 8.9994\u00b10.97 0.6\u00b10.0614 \n\nGel (1%) 7.62\u00b10.81 0.72\u00b10.08 \n\nCreme / Cream (1%) 8.46\u00b11.75 0.85\u00b10.175 \n\nMacroesferas secas / Dry beads (1.5%) 10.33\u00b13.13 0.7\u00b10.21 \n\nMacroesferas hidratadas \n\n/ Hydrated beads (1.5% ) \n6.42\u00b10.39 0.41\u00b10.002 \n\nMicropart\u00edculas / Microparticles (1% )      0.179\u00b10.018             0.0179\u00b10.0018  \n\n \n\nTabela  1- Fluxos em estado estacion\u00e1rio e coeficientes de permeabilidade (Kp) da cafe\u00edna nos diferentes \nsistemas testados (m\u00e9dia \u00b1DP).\n\n Steady-state flux values and permeability coefficients (Kp) of caffeine in the \ndifferent tested systems (mean \u00b1 SD).\n\nTable 1 - \n\n Catarina Pinto Reis et al.\n\n\n\n 236\n\nelevada concentra\u00e7\u00e3o de agente permeante n\u00e3o conduz \n[23]\n\nnecessariamente a um aumento do fluxo , sendo a \ncompara\u00e7\u00e3o dos valores de fluxo entre os diferentes \nsistemas de transporte neste estudo, portanto, adequada.\nO perfil de difus\u00e3o da cafe\u00edna nos diferentes sistemas de \nveicula\u00e7\u00e3o poder\u00e1 estar relacionado com as interac\u00e7\u00f5es \nentre os ve\u00edculos e a membrana, uma vez que foram \nobservadas diferen\u00e7as significativas nos fluxos da \nsolu\u00e7\u00e3o aquosa de cafe\u00edna e nos fluxos quando a cafe\u00edna \nse encontra associada aos diferentes ve\u00edculos (p = \n0,005). \nOs valores m\u00e9dios de fluxo do gel de cafe\u00edna foram \ninferiores aos do creme, mas essa diferen\u00e7a n\u00e3o foi \nestatisticamente significativa (p = 0,343). Estes \nresultados podem ser atribu\u00eddos a dois factores: se por \num lado, as caracter\u00edsticas reol\u00f3gicas do gel, como a \nviscosidade, poder\u00e3o dificultar a liberta\u00e7\u00e3o de cafe\u00edna a \npartir da formula\u00e7\u00e3o; por outro lado, apesar de ambas as \nformula\u00e7\u00f5es apresentarem uma natureza hidrof\u00edlica, \nessa caracter\u00edstica \u00e9 mais evidente na primeira, logo a \ncafe\u00edna ter\u00e1 mais afinidade para o gel, sendo libertada \nmais lentamente. Em resumo, o comportamento do gel \u00e9 \nclaramente marcado pela liberta\u00e7\u00e3o lenta e pela elevada \nafinidade da cafe\u00edna para o ve\u00edculo.\nA aplica\u00e7\u00e3o das macroesferas de alginato, vulgarmente \nreconhecidas como uma nova gera\u00e7\u00e3o de sistemas de \nveicula\u00e7\u00e3o para f\u00e1rmacos, proporcionou resultados \nsurpreendentes quando comparados com os obtidos \ncom as macroesferas hidratadas (p = 0,029). As \nmacroesferas secas (com um tamanho de 1 mm) \napresentaram um fluxo superior ao obtido com a \nsolu\u00e7\u00e3o aquosa, enquanto as macroesferas hidratadas \n(com um tamanho de 2-3 mm) apresentaram um fluxo \nde 1,4 vezes menor quando comparada com a solu\u00e7\u00e3o \nde refer\u00eancia. Em ambas as formula\u00e7\u00f5es devem ser \nconsiderados como principais factores n\u00e3o apenas a \nporosidade da membrana de alginato mas tamb\u00e9m o \nbaixo peso molecular da cafe\u00edna. No entanto, a press\u00e3o \nosm\u00f3tica de ambos os lados da membrana nas \nmacroesferas secas e o processo de hidrata\u00e7\u00e3o do \npol\u00edmero (entrada de \u00e1gua) promove claramente a \n\n[24]\ndifus\u00e3o livre da cafe\u00edna . No caso das macroesferas \nhidratadas, a lenta liberta\u00e7\u00e3o da cafe\u00edna s\u00f3 pode ser \nexplicada atrav\u00e9s da porosidade do pol\u00edmero, uma vez \nque o n\u00edvel de hidrata\u00e7\u00e3o da formula\u00e7\u00e3o mant\u00e9m a \ncafe\u00edna dentro da esfera e n\u00e3o permite difus\u00e3o livre da \n\n[25]\nmesma . Em suma, a for\u00e7a e elasticidade mec\u00e2nica \ndos n\u00facleos foram contrabalan\u00e7adas pelo processo de \nintumescimento do pol\u00edmero e a for\u00e7a motriz envolvida \nfoi o principal factor respons\u00e1vel pela taxa de liberta\u00e7\u00e3o \ne, por conseguinte, respons\u00e1vel pelo fluxo obtido. \nRealce-se que ser\u00e3o conduzidos outros estudos, que \nenvolver\u00e3o a aplica\u00e7\u00e3o de um agente de reticula\u00e7\u00e3o e \num processo de revestimento, com o objectivo de \nmodular a taxa de liberta\u00e7\u00e3o dos princ\u00edpios activos.\nAl\u00e9m disso, como ilustra a Fig. 4, os perfis de \n\n[23]\nlead to an increase of flux   and thus the comparison \nbetween the flux values of the different delivery \nsystems is appropriate.\nThe diffusion profile of caffeine in the different \ndelivery systems could be strongly explained by the \ninteractions between the vehicles and the membrane, \nsince significant differences were observed in terms of \nfluxes between aqueous solution of caffeine and \ncaffeine associated to the vehicles (p =0.005). The \nmean flux values with the caffeine gel were lower than \nwith the cream but this difference was not statistically \nsignificant (p=0.343). These results can be attributable \nto two factors: on the one hand, rheological \ncharacteristics of the gel, like viscosity, may hinder the \nrelease of caffeine from the formulation; on the other \nhand, even though both the gel and the cream (O/A) \nhave a hydrophilic nature, this characteristic is more \nevident in the first, thus caffeine had more affinity for \nthe gelling environment and it will be slowly released \nfrom the gel. In summary, the performance of the gel is \nclearly marked by a weak release and partitioning of \ncaffeine from this vehicle. \nThe use of alginate beads as a new generation of \ncontrolled drug delivery system proved to be a great \nchallenge and provided surprising results when \ncompared to those obtained by hydrated beads \n(p=0.029). Dry beads (particle size of 1 mm) exhibited \na higher flux than the aqueous solution while the \nhydrated beads (particle size around 2-3 mm) showed a \nflux 1.4 times lower than the reference solution. In both \ncases, not only the porosity of the alginate membrane \nbut also the lower molecular mass of caffeine should be \nconsidered as the major factors. However, the osmotic \npressure of both sides of the membrane in dry beads \nand the hydration process of the polymer (water input) \n\n[24]\nstrongly promotes the free diffusion of caffeine  . In \nthe case of hydrated beads, the restricted release of \ncaffeine can only be explained through the porosity of \nthe polymer since the hydration level of this \nformulation retains the caffeine inside the bead and \n\n[25]\ndoes not allow to a free diffusion of the drug  . In brief, \nthe elasticity and mechanical strength of the cores were \ncounterbalanced by the swelling process, and the \ninherent driving force was the main factor that explains \nthe release rate, therefore, the flux. Future studies \nshould be conducted with application of a cross linking \nagent or coating process in order to modulate the rate of \nthe active compound release.\nAs shown in Fig 4, the permeation profiles of caffeine \nencapsulated into alginate microparticles (particle size \nranged from 20 to 50 \u00ecm) were much different from \nevery other system and the highest differences in flux \nwere observed when microparticles were compared to \nhydrated beads formed by the external gelation method \n(p=0.007). Since the amounts of caffeine that \naccumulated in the receptor compartment were very \n\nInflu\u00eancia do sistema de liberta\u00e7\u00e3o na permea\u00e7\u00e3o de uma mol\u00e9cula hidrof\u00edlica\nThe influence of different delivery systems in the permeation of an hydrophilic active\n\n\n\n237\n\npermea\u00e7\u00e3o da cafe\u00edna encapsulada em micropart\u00edculas \nde alginato (tamanho da part\u00edcula variou entre 20 a 50 \n\u00ecm) foram muito diferentes aos obtidos com os \nsistemas anteriores. As diferen\u00e7as mais significativas \nforam observadas com as macroesferas hidratadas \npreparadas atrav\u00e9s do m\u00e9todo de gelifica\u00e7\u00e3o externa (p \n= 0,007). Neste caso, e uma vez que a quantidade de \ncafe\u00edna acumulada no compartimento receptor foi \nmuito baixa, foram realizados tempos de amostragem \nmais prolongados. O perfil de permea\u00e7\u00e3o da cafe\u00edna foi \nlinear at\u00e9 \u00e0s 48 horas e, em seguida, foi atingido um \nplateau. A liberta\u00e7\u00e3o do princ\u00edpio activo encapsulado \nparece ser limitada principalmente pela baixa \nporosidade das micropart\u00edculas, tamanho e estrutura da \npart\u00edcula. Neste sentido, estas micropart\u00edculas \nprovaram ser o menor sistema de part\u00edculas obtido e os \nnossos resultados sugerem que as micropart\u00edculas \npoder\u00e3o apresentar uma densa estrutura  em contraste \ncom macroesferas hidratadas formadas pelo m\u00e9todo de \ngelifica\u00e7\u00e3o externa.\nEm termos de porosidade, alguns estudos anteriores \ndemonstraram que a produ\u00e7\u00e3o de part\u00edculas pelo \nm\u00e9todo de gelifica\u00e7\u00e3o interna geralmente conduz \u00e0 \nforma\u00e7\u00e3o de estruturas mais porosas do que as \npart\u00edculas formadas pelo m\u00e9todo de gelifica\u00e7\u00e3o externa \n[9]\n\n. Por\u00e9m,  considerando aos resultados do fluxo obtidos \nneste estudo, que foram significativamente inferiores \naos obtidos com as macroesferas, assume-se que a \nporosidade poder\u00e1 n\u00e3o ser o principal factor. Por outro \nlado, no m\u00e9todo de gelifica\u00e7\u00e3o interna, os i\u00f5es de c\u00e1lcio \nest\u00e3o distribu\u00eddos uniformemente na solu\u00e7\u00e3o de \nalginato e difus\u00e3o de prot\u00f5es nas got\u00edculas vai induzir a \ngelifica\u00e7\u00e3o desde a superf\u00edcie at\u00e9 ao n\u00facleo da part\u00edcula, \n\n[12]\ndando origem a got\u00edculas homog\u00e9neas . Por \nconseguinte, assumimos que o outro factor poder\u00e1 estar \nrelacionado com o tamanho das part\u00edculas e n\u00e3o com a \ntecnologia de gelifica\u00e7\u00e3o. \u00c9 bem conhecido que o \ntamanho das part\u00edculas pode tamb\u00e9m influenciar o \ntamanho de poros. As macroesferas formadas pelo \nm\u00e9todo de gelifica\u00e7\u00e3o externa apresentaram um \ntamanho compreendido entre 2-3 mm. Pelo contr\u00e1rio, o \ntamanho das micropart\u00edculas variou entre 20 e 50 \u00ecm. \nNeste caso, esperamos observar poros mais pequenos \nno caso das micropart\u00edculas. Consequentemente, \nespera-se obter uma rede mais compacta de alginato e, \npor conseguinte, espera-se obter valores de fluxos \nreduzidos.\n\nConclus\u00e3o\n\nO tipo de ve\u00edculo \u00e9 um elemento vital no processo de \npermea\u00e7\u00e3o. Como n\u00e3o h\u00e1 nenhum ve\u00edculo universal, \ncada modelo molecular deve ser analisado \nindividualmente de forma a maximizar o seu potencial \nfarmacol\u00f3gico com a selec\u00e7\u00e3o de um sistema de \n\nlow, longer sampling times were taken. The \npermeation profile of caffeine was linear for up to 48 \nhours and then a plateau was emerged. The release of \nthe active compound seems to be limited mainly by the \nlow porosity of microparticles, size and their particle \nstructure. These microparticles prove to be the smallest \nparticle system and our results suggest that they may \nhave a dense amorphous structure in contrast to \nhydrated beads formed by external gelation.  In terms \nof porosity, previous study demonstrated that the \nproduction of particles using internal gelation method \ngenerally allows to the formation of more porous than \n\n[9]\nthose formed via external gelation   but since the flux \nvalue of the microparticles obtained in this study was \nsignificantly lower comparing with beads, the porosity \ndoes not seem to be the main factor that explains \nprevious results.  On the other hand, in internal \ngelation method, calcium ions are homogeneously \ndistributed in the alginate solution initially, thus \ndiffusion of protons into the pre-gel droplets will \ninduce gelation starting at the surface, giving rise to \n\n[12]\nhomogenous droplets  . Thus, we assumed that the \nother factor could be related to the particle size and not \nrelated to the gelation technology. It is well-known that \nparticle size may also influence porous size. Beads \nformed by external method were around 2-3 mm. In \ncontrast, microparticles ranged from 20-50 \u00ecm. In this \ncase, we expected to have small pores in the \nmicroparticles. Consequently, a more compact alginate \nnetwork is present in microparticles and thus it may \nachieve to the lowest fluxes.\n\nConclusion\n\nThe type of vehicle is key issue of the permeation \nprocess. Since there is no universal vehicle, each \nmolecular model must be analyzed individually in \norder to maximize its pharmacological potential with a \nsuitable delivery system. \n\n Catarina Pinto Reis et al.\n\n\n\n238\n\nveicula\u00e7\u00e3o adequado.\nEste estudo abordou o impacto do intumescimento das \nmacroesferas secas na liberta\u00e7\u00e3o do agente permeante. \nTal facto demonstrou ser respons\u00e1vel por um \ncomportamento diferente quando comparado com as \nformula\u00e7\u00f5es tradicionais, tais como, o creme ou o gel. \nPor outro lado, as macroesferas hidratadas e \nmicropart\u00edculas foram capazes de retardar a liberta\u00e7\u00e3o \nde cafe\u00edna e demonstraram ser potenciais sistemas \npromissores para a aplica\u00e7\u00e3o t\u00f3pica de v\u00e1rios princ\u00edpios \nactivos.\nEstes resultados sugerem que a resposta para conseguir \numa formula\u00e7\u00e3o optimizada n\u00e3o  depende apenas de um \nconhecimento completo do perfil f\u00edsico-qu\u00edmico dos \nf\u00e1rmacos e excipientes mas tamb\u00e9m das propriedades e \nos mecanismos inerentes \u00e0 ac\u00e7\u00e3o do sistema de \nveicula\u00e7\u00e3o, quando este \u00e9 considerado como uma \nunidade.\nFuturamente, ser\u00e3o conduzidos outros estudos que \nenvolver\u00e3o um composto modelo lipof\u00edlico, seguido \npor m\u00e9todos experimentais com a pele humana e a \naplica\u00e7\u00e3o desta tecnologia a outros f\u00e1rmacos mais \nrelevantes a n\u00edvel terap\u00eautico.\n\nThis study brought into the limelight the impact of the \nswelling property of the dry beads in the release of the \nmodel permeant, which was responsible for a different \nperformance of this system when compared to the well-\nknown traditional formulations such as cream and gel. \nConversely, hydrated beads and microparticles were \nable to delay the release of caffeine and showed \npotential to become promising systems for the topical \ndelivery of several active compounds. \nThese results lead to the conclusion that the answer to \nachieve an optimized formulation is not only a \ncomplete knowledge of the physicochemical profile of \nthe drugs and excipients but also the properties and \ninherent mechanisms of action of the delivery system \nas a unit.\nFuture studies will be conducted with a lipophilic \nmodel compound, followed by experimental methods \nwith human skin and more therapeutically relevant \ndrugs.\n\nInflu\u00eancia do sistema de liberta\u00e7\u00e3o na permea\u00e7\u00e3o de uma mol\u00e9cula hidrof\u00edlica\nThe influence of different delivery systems in the permeation of an hydrophilic active\n\nRefer\u00eancias / References\n\n[1] Murdan S. Organogels in drug delivery. Expert Opin Drug Deliv 2005; 2: 489-505.\n[2] Hair PI, Keating GM, McKeage K. Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related \nchronic pain.  Drugs 2008; 68: 2001-2009.\n[3] Cilurzo F, Minghetti P, Gennari CG, Casiraghi A, Montanari L. A novel polymethylmethacrylate hydrophilic adhesive \nmatrix intended for transdermal patch formulations. Drug Deliv 2010; 17:171-177.\n[4] Kaushik D, Batheja P, Kilfoyle B, Rai V, Michniak-Kohn B. Percutaneous permeation modifiers: enhancement versus \nretardation. Expert Opin Drug Deliv 2008; 5: 517-529.\n[5] Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromatogr B Analyt Technol \nBiomed Life Sci 2004; 5: 231-245.\n[6] Santos P, Watkinson AC, Hadgraft J, Lane ME. Application of microemulsions in dermal and transdermal drug delivery. \nSkin Pharmacol Physiol 2008; 21: 246-259.\n[7] Blaine G. Experimental observations on absorbable alginate products in surgery: gel, film, gauze and foam. Ann Surg 1947; \n125:102-114.\n[8] Gacesa P. Alginates. Carbohydr Polym 1988; 8: 161-182.\n[9] Vandenberg GW, Nou\u00e8 JDL. Evaluation of protein release from chitosan-alginate microcapsules produced using external or \ninternal gelation. J Microencapsul 2001; 18: 433-441.\n[10] Chan LW. Production of alginate microspheres by internal gelation using emulsification method. Int J Pharm 2002; 242: \n259-262.\n[11] Reis CP, Neufeld RJ, Vilela S, Ribeiro AJ, Veiga F. Review and current status of emulsion/dispersion technology using an \ninternal gelation process for the design of alginate particles. J Microencapsul 2006; 23: 245-257.\n[12] Quong D, Neufeld RJ, Skjak-Braek G, Poncelet D. External versus internal source of calcium during the gelation of \nalginate beads for DNA encapsulation. Biotechnol Bioeng 1998; 57: 438-446.\n[13] Redenbaugh K, Paasch BD, Nichol JW, Kossler ME, Viss PR, Walker KA. Somatic seeds: encapsulation of asexual plant \nembryos. Bio Technol 1986; 4: 797-801.\n[14] Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-910.\n[15] Lamberti FV, Sefton MV. Microencapsulation of erythrocytes in Eudragit-RL-coated calcium alginate. Biochimica et \nBiophysica Acta (BBA) - Biomembranes 1983; 759: 81-91.\n\n\n\n 239\n\n Catarina Pinto Reis et al.\n\n[16] Provost H, Divies C, Rousseau E. Continuous production with Lactobacillus bulgarius and Streptococcus termophillus \nentrapped in calcium alginate. Biotechnol Lett 1985; 7: 247-252.\n[17] Shiotani T, Yamane T. A horizontal packed-bed bioreactor to reduce carbon dioxide gas holdup in the continuous \nproduction of ethanol in immobilized yeast cells. Eur J Appl Microbiol Biotechnol 1981; 13: 96-101.\n[18] Salib NN, El Menshawy MA, Ismail AA. Utilization of sodium alginate in drug microencapsulation. Pharm Ind 1978; 40: \n1230-1234.\n[19] Badwan AA, Abumalooh A, Sallam E, Abukalaf A, Jawan O. Sustained-release drug delivery system using calcium \nalginate beads. Drug Dev Ind Pharm 1985; 11: 239-256.\n[20] Gray CJ, Dowsett J. Retention of insulin in alginate gel beads. Biotechnol Bioeng 1988; 31: 607-612.\n[21] Canon K. Electrostastic image development toners. Japan, 1984: 59170853.\n[22] Burns MA, Kvesitadze GI, Graves DJ. Dried calcium alginate/magnetite spheres:a new support for chromatographic \nseparations and enzyme immobilization. Biotechnol Bioeng 1985; 27: 137-145.\n[23] Akhter SA, Barry BW. Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited \ndrug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidone. J Pharm Pharmacol 1985; 37: 27-37.\n[24] Sugawara S, Imai T, Otagiri M. The controlled release of prednisolone using alginate gel. Pharm Res 1994; 11: 272-277.\n[25] Thu B. Alginate polycation microcapsules.I Interaction between alginate and polycation. Biomaterials 1996; 17: 1031-\n1040."}]}}}